Inbar Pomeranchik

Gründer bei BioDiligence Partners, Inc.

47 Jahre

Consumer Services

Health Technology

Energy Minerals

Profil

Inbar Maymon Pomeranchik is the founder of BioDiligence Partners, Inc., Agchimedes.
Currently, Dr. Pomeranchik holds the position of Non-Executive Director at Ananda Developments Plc since 2018 and is also a Director at Iaso Corp.
In the past, Dr. Pomeranchik served as a Director at Top Strike Resources Corp.
from 2018 to 2019, an Independent Director at CNBX Pharmaceuticals, Inc. from 2021 to 2023, and a Director at NRGene Technologies Ltd.
from 2021 to 2022.
In terms of education, Dr. Pomeranchik obtained a doctorate degree from The Hebrew University of Jerusalem in 2008 and another doctorate degree from the Weizmann Institute of Science in 2010.

Aktive Positionen von Inbar Pomeranchik

Unternehmen	Position	Beginn
Ananda Developments Plc Ananda Developments Plc Investment ManagersFinance Ananda Developments Plc engages in the provision of cannabinoid medicines for the treatment of complex, chronic inflammatory pain conditions. The company was founded on January 19, 2018, and is headquartered in London, the United Kingdom.	Direktor/Vorstandsmitglied	04.07.2018
BioDiligence Partners, Inc.	Gründer	-
Iaso Corp.	Direktor/Vorstandsmitglied	-
Agchimedes	Vorstandsvorsitzender	-

Alle aktiven Positionen von Inbar Pomeranchik

Ehemalige bekannte Positionen von Inbar Pomeranchik

Unternehmen	Position	Ende
CNBX PHARMACEUTICALS INC.	Direktor/Vorstandsmitglied	31.01.2023
NRGENE TECHNOLOGIES LTD	Direktor/Vorstandsmitglied	16.08.2022
VENCANNA VENTURES INC.	Direktor/Vorstandsmitglied	26.04.2019